Mike Ouimette - 23 Jan 2024 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role: General Counsel & Corp. Sec'y
Signature: /s/Mike Ouimette
Issuer symbol: PLRX
Transactions as of: 23 Jan 2024
Net transactions value: $0
Form type: 4
Filing time: 24 Jan 2024, 16:57:33 UTC
Previous filing: 19 Jan 2024
Next filing: 11 Jul 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PLRX	Common Stock	Award	$0	+31,500	+57%	$0.000000	86,746	23 Jan 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PLRX	Stock Option (Right to Buy)	Award	$0	+63,000		$0.000000	63,000	23 Jan 2024	Common Stock	63,000	$17.44	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These are restricted stock units that vest in three substantially equal annual installments beginning January 16, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date.
F2	1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date.